『NEJM This Week』のカバーアート

NEJM This Week

NEJM This Week

著者： NEJM Group
無料で聴く

概要

 Concise summaries of everything published in the latest weekly issue of the New England Journal of Medicine (NEJM). NEJM publishes new medical research findings, review articles, and editorial opinion on topics of importance to biomedical science and clinical practice.Copyright 2026 Massachusetts Medical Society 衛生・健康的な生活 身体的病い・疾患
エピソード
  • NEJM This Week — March 26, 2026

    NEJM This Week — March 26, 2026
    2026/03/25
    This week, we present new clinical trials on immunotherapy for stage III mismatch repair–deficient colon cancer, early surgery for asymptomatic aortic stenosis, an approach to dengue virus suppression, and advances in gene and prime-editing therapies for rare disorders. We also review minipuberty. We follow the case of a 12-year-old girl with altered mental status and persistent hypoglycemia, and we explore Perspectives on corporate influences on health, vaccine communication, antitrust policy, conflicts of interest, and the meaning of the number needed to treat.
    続きを読む 一部表示
    28 分
  • NEJM This Week — March 12, 2026

    NEJM This Week — March 12, 2026
    2026/03/11
    This week, we explore new evidence comparing oral anticoagulants for acute venous thromboembolism, treatment for chemotherapy-induced thrombocytopenia, and early results of gene therapy for inherited deafness. We also examine evolving strategies for chronic lymphocytic leukemia, review the management of polymyalgia rheumatica, and present a case discussion of a woman with chest pain, dyspnea, and syncope. We explore gastric cancer prevention, competency-based billing, the health consequences of immigration enforcement, access to high-cost gene therapies, and we present a Perspective on good compressions.
    続きを読む 一部表示
    26 分
  • NEJM This Week — February 26, 2026

    NEJM This Week — February 26, 2026
    2026/02/25
    This week, we explore a new standard of care for high-risk HER2-positive early breast cancer, long-acting therapy for people with HIV facing adherence challenges, a first-in-class trial of a p53 reactivator, and tecovirimat for mpox. We review group B streptococcal disease and a revealing case of prosthetic joint infection. Perspectives examine the role of folate therapy, Medicare drug-price negotiation, AI in medical education, and incidental findings.
    続きを読む 一部表示
    27 分
まだレビューはありません